Medicare Part D — delivering prescription drugs to seniors — has been a success since President Bush introduced it. And the Obama administration plans to threaten that achievement.

The Medicaid drug program wasted $329 million nationwide in 2009 from states all too frequently reimbursing for a version of a drug that is more costly than another product with the exact same active ingredient, dose, form and bottle size.

President Obama promised that the brunt of any financial reckoning will fall mostly only on those making more than $250,000 annually. Under his healthcare plan, the economic agony starts at income levels that fall much lower than that.

While Republicans have a lot of problems to contend with as the elections approach, it appears that the new prescription drug benefit is not one of them.

Should the government negotiate the prices of pharmaceuticals covered by the new Medicare Part D prescription drug benefit? The incoming Democratic leadership in Congress has made Medicare price negotiation a top policy priority, but controversy rages over precisely what that might entail and whether it would reduce drug costs in...

Richard Foster, Medicare's chief actuary, will present the major findings of the Medicare trustees' report, to be released in early May. Will the addition of the new drug benefit, which began in January, have a significant effect on the long-term financial condition of Medicare, or is there reason for optimism?...

We have made promises in Medicare that cannot be kept, and we have compounded those promises with the Medicare Modernization Act.